// App-Quantinova.ai

: Inhibition of Plasminogen Activator Inhibitor Type 1 in Experimental Venous Thrombosis

Researchers

Presenter

  • Maxim E Shaydakov

Principal Investigators

  • Joshua Rainey

  • Daniel A Lawrence

  • Fedor Lurie

  • Jose A Diaz

Medical Centers

  • Orthopaedics, Univ of Utah, UT

  • University of Michigan, Ann Arbor, MI

  • Vanderbilt University Medical Center, Nashville, TN

  • Central Michigan Univ, Saginaw, MI

  • Jobst Vascular Inst, Toledo, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Plasminogen activator ihnibitor-1

  • D-dimer

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

  • DMSO

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved